MoneyWorks4Me

Themis Medicare - Quaterly Results

21 May 2022 Evaluate
The sales surged to Rs. 797.97 millions, up 29.18% for the March 2022 quarter as against Rs. 617.73 millions during the corresponding quarter previous year.Profit saw a slight increase of 10.78%to Rs. 75.51  millions from Rs. 68.16 millions.Operating Profit saw a handsome growth to 162.62 millions from 134.89 millions in the quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 797.97 617.73 29.18 3946.14 2306.70 71.07 3946.14 2306.70 71.07
Other Income 18.38 8.82 108.39 65.41 36.22 80.59 65.41 36.22 80.59
PBIDT 162.62 134.89 20.56 1021.92 535.06 90.99 1021.92 535.06 90.99
Interest 19.28 30.87 -37.54 87.74 127.12 -30.98 87.74 127.12 -30.98
PBDT 143.34 104.02 37.80 934.18 407.94 129.00 934.18 407.94 129.00
Depreciation 23.89 23.81 0.34 94.80 85.46 10.93 94.80 85.46 10.93
PBT 119.45 80.21 48.92 839.38 322.48 160.29 839.38 322.48 160.29
TAX 43.94 12.05 264.65 223.81 56.28 297.67 223.81 56.28 297.67
Deferred Tax 13.94 12.05 15.68 56.31 56.28 0.05 56.31 56.28 0.05
PAT 75.51 68.16 10.78 615.57 266.20 131.24 615.57 266.20 131.24
Equity 92.00 91.88 0.13 92.00 91.88 0.13 92.00 91.88 0.13
PBIDTM(%) 20.38 21.84 -6.67 25.90 23.20 11.64 25.90 23.20 11.64
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..